Articles

The Cost Of Using Robots In Surgery

ROBOT-ASSISTED SURGERIES—a technology oft-touted by hospitals—are longer and more expensive than other types of minimally invasive surgeries, according to a growing body of studies. And in some types of surgery, they have a lower success rate. Two studies published online last week in JAMA compared robotic-assisted surgeries to laparoscopic surgeries. Both are minimally invasive procedures done ...

CVS Sets Next-Day Delivery Of Drugs

CVS Health Corp. is launching next-day delivery of prescription medication, a move that comes as the drugstore giant faces declining retail sales and potential competition from Amazon.com Inc.
 CVS on Monday said it would offer the service nationwide starting early next year, and same-day delivery in some urban areas. In Manhattan, the company will offer free same day delivery service starting Dec. 4.

Cardinal Health CEO to Step Down

Cardinal Health Inc. said Monday that Chief Executive George Barrett will step down in January after more than eight years in the post, as pricing pressure for generic drugs has weighed on the company in recent months.
 Mr. Barrett, 62 years old, will remain in his role as executive chairman until the company's shareholder meeting in November 2018.

Immunotherapy Treatments for Cancer Gain Momentum

The science of using immunotherapy to treat cancer is advancing rapidly, marked by the National Cancer Institute's recent disclosure that a metastatic breast-cancer patient is now cancer-free, regulators' expected approval of a major lymphoma treatment this fall, and the unveiling Thursday of a partnership between government researchers and drug makers.

Gene Editing Is Here, and Desperate Patients Want It

Should Americans be allowed to edit their DNA to prevent genetic diseases in their children? That question, which once might have sounded like science fiction, is stirring debate as breakthroughs bring the idea closer to reality. Bioethicists and activists, worried about falling down the slippery slope to genetically modified Olympic athletes, are calling for more regulation.

Pfizer Tightens Focus on Prescription Drugs

Pfizer Inc. said Tuesday it is exploring a sale or spin-off of its consumer-health business, the company's latest move to double down on prescription drugs and a potential prelude to more deal-making.
 The drugmaker left open the possibility of holding on to the unit, but Pfizer has been cutting ties with nonpharmaceutical businesses, as rivals have pushed to consolidate in the $233 billion global consumer